Oura's 95% is a test result, not a sensor spec, and that is where the lawsuit lands
A proposed class action puts a marketing number on trial rather than a device. Any wearable that quantified inference against a sleep lab carries the same exposure.
The Product Desk
What happened
- Clarkson Law Firm filed a proposed class action in San Francisco on Thursday accusing Oura of misleading consumers about sleep-tracking accuracy.
- The case sits in the Northern District of California and names both Oura Inc. and Finnish parent Oura Health Oy.
- Oura told The Next Web it stands behind its science, research and accuracy claims; it did not immediately respond to TechCrunch.
Why it matters
- Who's exposed exposure The exposure attaches to the percentage, not the inference. Vendors that said their device estimates sleep stages are describing a feature; vendors that published an agreement figure against a...
- What doesn't add up contradiction Both sides argue from comparisons against polysomnography, so the trial does not turn on whether the ring has electrodes.
- Who has to decide decision With a confidential IPO filing already lodged, Oura has to choose between defending the figure through discovery or restating it, and restating it under litigation pressure reads as a concession...
- What it sets up precedent The EU route no longer requires an individual plaintiff: designated consumer bodies can now bring collective redress over unfair commercial practices, which makes the same advertised figure...
Next story · Product · Sep 30
Oura delays its $2.2bn IPO as shares reportedly head for the low end of its rangeConfirmed4 publishers
The number in dispute was never a hardware specification. "95% Sleep Staging Accuracy compared to clinical sleep lab" is the reported output of a comparison against something else [3], and the something else is polysomnography, which reads brain activity, eye movement and muscle tone through electrodes [4]. That construction is what makes the claim reachable. A vendor saying its ring estimates sleep stages is describing a feature. A vendor publishing an agreement percentage against a clinical reference has made a representation about a test, and tests have protocols, samples and scoring rules that a court can ask to see.
The sensor list explains why the percentage has to come from a model rather than a reading. The newest ring carries a photoplethysmogram using red and green LEDs for heart rate, blood oxygen and breathing, temperature sensors and an accelerometer [7]. None of those track brain activity, eye movement, electrical heart activity or muscle activity [8]. The complaint's phrasing for what fills the gap is "AI models... doing guesswork as to what may be happening, based on improper inputs" [9], and more bluntly, that "sleep happens in the brain, not on one's finger" [11].
The arithmetic is the part worth sitting with. Oura previously told customers 79% accuracy and more recently 95% [10], a climb of 16 points in the advertised figure [21]. The study the complaint leans on, covering 45 patients, put overall sleep stage classification accuracy at 53.18% and found REM overestimated by an average of 31.56 minutes [22]. Against the advertised figure that is a gap of 41.82 percentage points [20]. Neither percentage arrives with a stated protocol in the material available: Oura's answer is that its staging has compared favourably against polysomnography in multiple studies [23], which is a claim about a different set of comparisons rather than a rebuttal of that one.
Oura's fallback is already visible in the pleading, which alleges the company conceded the difference from a sleep study only in technical materials most customers will not read [15]. That is the standard shape of a California advertising case, and it is weaker here because the number was pushed through celebrity endorsements and influencer marketing [19] onto a device priced at $300 and up [16].
There is no regulator holding the other end of this. Wearables sit in a wellness category where accuracy can be supported by studies but the device is not treated by regulators as capable of medical diagnosis [18], so nobody certifies the percentage before it ships. The only venues that test it are advertising statutes, which is exactly what the seven counts do, including fraud by misrepresentation and California's Unfair Competition and False Advertising Laws [6].
The remedy is the expensive half. Damages are a number Oura can reserve against; a corrective advertising injunction requiring prominent disclaimers [6] rewrites the page that sells the ring, in the same year the company filed confidentially for a US IPO on an $11bn valuation [12]. Ryan Clarkson of the filing firm frames the harm as behavioural, saying people structure their days and interpret how they feel around the figures on screen [17], and years of users reporting that the ring called a bad night optimal [25] is the evidentiary base for that.
What to watch
- Whether Oura's validation studies enter the docket, and how each one defines the word accuracy.
- Whether any designated EU consumer body takes up the same 95% figure under the Representative Actions Directive.
- Whether the 95% line stays on the product page, is quietly restated, or gains a disclaimer before any court orders one.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence64
- Adoption58
- Hype gap+24
- Incentives74
- Confidence66
Perspective Coverage
3 publishers- Builder
- Builder 30%
- Operator
- Operator 38%
- Investor
- Investor 32%
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
A proposed class action was filed on Thursday by Clarkson Law Firm in San Francisco against smart ring maker Oura.
- [2]
The proposed class action was filed in the Northern District of California and names both Oura Inc. and its Finnish parent Oura Health Oy as defendants.
- [3]
Oura has advertised "95% Sleep Staging Accuracy compared to clinical sleep lab" on its product pages.
- [4]
A polysomnography sleep study measures brain activity, eye movement and muscle tone through electrodes, none of which a ring has.
- [5]
The complaint describes Oura's sleep stages as "AI-generated guesses" with roughly "a coin flip's chance" of being right.
- [6]
The case carries seven counts, including fraud by misrepresentation and breaches of California's Unfair Competition Law and False Advertising Law, and asks for damages plus a corrective advertising injunction requiring prominent disclaimers.
- [7]
The newest Oura ring includes a photoplethysmogram sensor using red and green LEDs to measure heart rate, blood oxygen levels and breathing, sensors for body temperature, and an accelerometer.
- [8]
Those sensors do not track brain activity, eye movement, electrical activity in the heart, or muscle activity, the markers typically tracked in a clinical sleep setting.
- [9]
The lawsuit states: "Instead, Oura's AI models are doing guesswork as to what may be happening, based on improper inputs."
- [10]
The complaint says Oura told customers its rings could achieve 79% accuracy in their measurements, and more recently claimed 95% sleep-staging accuracy compared with clinical sleep labs.
- [11]
The complaint alleges Oura cannot measure sleep or cycles because "sleep happens in the brain, not on one's finger."
- [12]
Oura filed confidentially for a US initial public offering in May, after reaching an $11bn valuation that made it Europe's most valuable consumer health hardware company.
- [13]
The same 95% figure is marketed to European buyers, where the Unfair Commercial Practices Directive prohibits misleading claims about a product's main characteristics and about "the results and material features of tests or checks carried out on the product."
- [14]
Since June 2023 the Representative Actions Directive has let designated consumer bodies bring collective redress actions across the EU, and unfair commercial practices sit in its annex.
- [15]
The lawsuit alleges Oura admits its smart rings are not the same as a sleep study only in technical materials most customers will not read.
- [16]
Oura rings are priced at $300 and up.
- [17]
Ryan Clarkson, co-founder and managing partner at Clarkson Law Firm, said people structure their days, interpret the way they feel, and design their lives around inaccurate figures produced by these devices.
- [18]
Wearable makers sit in a wellness grey area where feature accuracy can be backed by studies but the devices cannot be considered truly capable of medical diagnosis by regulators.
- [19]
Oura continued advertising its rings, amplified through celebrity endorsements and influencer marketing, without acknowledging the limitations of their sleep tracking, according to the lawsuit.
- [20]
The advertised 95% figure and the 53.18% figure cited in the complaint differ by 41.82 percentage points.
- [21]
Oura's advertised accuracy figure rose by 16 points, from 79% to 95%.
- [22]
The complaint cites a study of 45 patients that found overall sleep stage classification accuracy of 53.18%, with REM sleep overestimated by an average of 31.56 minutes.
- [23]
An Oura spokesperson said "We stand behind our science, research, and accuracy claims," adding that its sleep staging has been compared favourably against polysomnography in multiple studies.
- [24]
Oura did not immediately respond to TechCrunch's request for comment.
- [25]
The lawsuit follows years of Oura users publicly complaining about sleep accuracy, with some saying they felt they slept poorly but were told their sleep had been optimal.
Sources
3 independent publishers whose own reporting we read for this story.
- gizmodo.comProposed Oura Lawsuit Highlights Wearables’ Health Limitations
1 article · August 21, 2026
- techcrunch.comOura faces lawsuit accusing it of misleading consumers about sleep-tracking accuracy
1 article · August 21, 2026
- thenextweb.comA lawsuit says Oura’s sleep stages are AI guesses with a coin flip’s odds
1 article · August 23, 2026
Topics and entities
Topics
- Wearable Accuracy Claims
- Digital Health Regulation
- EU Consumer Redress
- Pre-IPO Legal Risk
- AI Inference Versus Measurement
- Consumer Class Action Litigation
Entities
- Oura Ring 5
- Unfair Commercial Practices Directive
- Representative Actions Directive
- California Unfair Competition Law
- Oura
- Clarkson Law Firm
- Northern District of California